News

The rapid advancements in artificial intelligence are permeating various sectors at an extraordinary pace, including laboratory medicine.Autobio has successfully implemented the DeepSeek localisation, officially introducing the DeepSeek-R1 model, and has completed the transformation and upgrading of the core functions of the 'Autobio AI Clinical Decision Aid System'.

The system's advanced capabilities, including its ability to comprehensively analyse vast amounts of data, interpret test reports, and identify influencing factors, have been instrumental in enhancing the system's performance.

Autobio AI test clinical decision-making system' access DeepSeek, for example, can achieve a number of upgrades:

01 Disease Risk Analysis

By using DeepSeek for in-depth mining and analysis of vast medical data and clinical research, and combining it with the existing disease risk prediction model in the AI test clinical decision system, the accuracy and comprehensiveness of disease risk assessment can be improved.

02 Detection And Identification Of Pathogenic Bacteria

DeepSeek's advanced reasoning and data analysis capabilities enable comprehensive analysis of all patient clinical information, facilitating accurate identification of colonising bacteria, pathogenic bacteria, and normal flora. This enhances the reliability of clinical diagnoses.

03 Drug Influencing Factor Analysis

Using DeepSeek, the patient's 'one complaint and five histories' and the test knowledge base can be analysed in depth to identify the potential interference of drugs on test results. Once the risk is detected, the system will issue an early warning via a real-time message to assist clinical analysis in locating the problem, thereby providing strong support for test work and clinical decision-making.   

04 Intelligent Knowledge Quiz

The intelligent knowledge quiz uses DeepSeek technology to accurately interpret user queries. The technology enables the system to efficiently extract relevant information from vast medical literature, clinical guidelines and cases, and to carry out in-depth logical reasoning.When faced with complex medical questions, the system leverages the power of DeepSeek to provide precise and detailed answers, supported by thorough explanations and justifications. The combination with DeepSeek significantly improves the speed and accuracy of users' access to medical information, thus assisting in testing and clinical decision-making.

By accessing DeepSeek and combining it with RAG technology, Autobio has upgraded the functions of intelligent Q&A for tests, intelligent interpretation of test reports and analysis of influencing factors, marking another breakthrough for the company in the application of AI technology.

Looking to the future, the company will continue to explore and expand the potential of AI technology in all aspects of disease prevention, diagnosis, treatment and management, and promote the intelligent development of test medicine, with the aim of making greater contributions to global healthcare.